2018
DOI: 10.1007/164_2018_179
|View full text |Cite
|
Sign up to set email alerts
|

Exploring the Therapeutic Landscape of Sphingomyelinases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
11
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 140 publications
0
11
0
Order By: Relevance
“…Combing of I. scapularis genome showed the presence of several other sphingomyelinases that are currently addressed in tick-LGTV interactions and exosome-mediated transmission of flaviviruses. In all animals, plants, and fungi, and in some of the prokaryotes and viruses, sphingolipids are the ubiquitous constituents of all the membranes, which include plasma membranes and membranebound organelles (Raposo and Stoorvogel, 2013;Schneider-Schaulies and Schneider-Schaulies, 2015;Bezgovsek et al, 2018;Shanbhogue and Hannun, 2018). In order to convert SM lipids into phosphocholine and ceramide, SMases have to be active and functional to hydrolyze this process (Clarke et al, 2006;Bartke and Hannun, 2009).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Combing of I. scapularis genome showed the presence of several other sphingomyelinases that are currently addressed in tick-LGTV interactions and exosome-mediated transmission of flaviviruses. In all animals, plants, and fungi, and in some of the prokaryotes and viruses, sphingolipids are the ubiquitous constituents of all the membranes, which include plasma membranes and membranebound organelles (Raposo and Stoorvogel, 2013;Schneider-Schaulies and Schneider-Schaulies, 2015;Bezgovsek et al, 2018;Shanbhogue and Hannun, 2018). In order to convert SM lipids into phosphocholine and ceramide, SMases have to be active and functional to hydrolyze this process (Clarke et al, 2006;Bartke and Hannun, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…In order to convert SM lipids into phosphocholine and ceramide, SMases have to be active and functional to hydrolyze this process (Clarke et al, 2006;Bartke and Hannun, 2009). SM consisting of phosphocholine and ceramide or a phospho-ethanolamine head group is a type of sphingolipid found in all animal membranes (Hannun and Obeid, 2018;Shanbhogue and Hannun, 2018). It represents 85% of all sphingolipids in human and accounts to 10-20 mol % of the plasma membrane lipids (van Meer and Lisman, 2002;Futerman, 2006;Bartke and Hannun, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…It has been reported that free ARA is readily incorporated by S. mansoni (56), and likely activates the parasite voltage-gated channels, and enzymes, namely tegumentassociated nSMase with subsequent apical SM hydrolysis, and exposure of the otherwise hidden surface membrane antigens to antibody-mediated effector functions, and parasite demise. Sphingomyelin degradation leads to accumulation of intra worm apoptotic signals (57). Arachidonic acid, a powerful host phagocyte NADPH oxidase activator, contributes to inflammation via eliciting massive production of reactive oxygen (ROS) and nitrogen (RNS) species (58), which are harmful to the schistosomes and perhaps responsible for egg attrition, immediately upon trapping.…”
Section: Arachidonic Acid Is a Critical Mediator Of Protection In Thementioning
confidence: 99%
“…nSMases are further classified into anionic phospholipid (APL)independent nSMase1, APL-dependent nSMase2, a Bovine nSMase3, and a mitochondria-associated nSMase4. nSMase2 has been widely studied for its roles in cell growth, stress responses, and exosome release (11)(12)(13). Dysregulation in nSMase2 activity has been implicated in cancer, cardiovascular, and neurological conditions, such as Alzheimer's disease (14,15), thus making it an important therapeutic target.…”
mentioning
confidence: 99%
“…The NTD contains two hydrophobic segments, HS1 and HS2, that are important for APL-mediated allosteric activation of nSMase2. The first APL-binding site is between HS1 and HS2 on nSMase2, and the second APL-binding site includes a portion of the JX region (13,18). The insertion region is presumed to regulate nSMase2 through its five phosphorylation sites and calcineurin-binding site (19); however, deletion of this region does not affect basal nSMase2 activity (20).…”
mentioning
confidence: 99%